Authors: E S Erman L V Osidak V F Sukhovetskaya V P Drinevskii
Publish Date: 2009/12/10
Volume: 148, Issue: 2, Pages: 270-
Abstract
Prophylactic efficiency and safety of anaferon pediatric formulation in children aging 1 month to 4 years including sickly children was proven The use of the preparation in children reduced the incidence of acute respiratory infections alleviated the course of the disease and decreased the incidence of detection of viral antigens in nasal meatuses
Keywords: